Company profile for RQ Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RQ Bio’s mission has been to develop medicines based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from current and future variants of viral infections. RQ Bio has achieved this by combining innovative excellence in core areas to create a smarter approach to antibody generation. RQ Bio has multiple sources of leads and a deep collaboration ...
RQ Bio’s mission has been to develop medicines based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from current and future variants of viral infections. RQ Bio has achieved this by combining innovative excellence in core areas to create a smarter approach to antibody generation. RQ Bio has multiple sources of leads and a deep collaboration with the University of Oxford. RQ Bio was founded by scientific experts previously involved with the UK BIA Antibody Taskforce.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
7th Floor Lynton House, 7-12 Tavistock Square London, WC1H 9LT,
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/01/09/3006867/0/en/RQ-Bio-welcomes-positive-CHMP-opinion-on-Kavigale-for-prevention-of-COVID-19-in-immunocompromised-individuals.html

GLOBENEWSWIRE
09 Jan 2025

https://www.prnewswire.com/news-releases/rq-bio-strengthens-board-with-industry-leading-infectious-disease-experts-joining-as-non-executive-directors-301742967.html

PR NEWSWIRE
09 Feb 2023
Antibody discovered by RQ Bio enters pivotal research phase
Antibody discovered by RQ Bio enters pivotal research phase

05 Jan 2023

// John Pinching PHARMA TIMES

https://www.pharmatimes.com/news/antibody_discovered_by_rq_bio_enters_pivotal_research_phase_1484925

John Pinching PHARMA TIMES
05 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty